2) Doxazosin mesylate
甲磺酸多沙唑嗪
1.
Effect of doxazosin mesylate on plasma high-sensitivity C-reactive protein and nitric oxide in patients with essential hypertension;
甲磺酸多沙唑嗪对高血压病患者血浆高敏C-反应蛋白和一氧化氮的影响
2.
Double blind randomized multicenter clinical study on doxazosin mesylate for treatment of hypertension;
甲磺酸多沙唑嗪治疗高血压的多中心随机双盲临床研究
3.
A HPLC method for determination of doxazosin mesylate capsules was established.
建立了测定甲磺酸多沙唑嗪胶囊的HPLC法。
3) doxazosin
甲磺酸多沙唑嗪
1.
HPLC for determination of doxazosin in tablets;
甲磺酸多沙唑嗪片剂的含量、含量均匀度和溶出度的测定
2.
Doxazosin and Terazosin were added to 4 mg/d if DBP was > 90 mmHg aft.
目的 评价新一代α_1受体拮抗剂甲磺酸多沙唑嗪的降压疗效及安全性,并与盐酸特拉唑嗪相比较。
3.
OBJECTIVE: Single oral dose study was performed to assess the safety and toleration of domestic doxazosin mesylate in healthy volunteers.
目的：在健康志愿受试者中评价单次口服国产甲磺酸多沙唑嗪的安全性和耐受性。
4) Doxazosin mesylate(Cardura XL)
甲磺酸多沙唑嗪(可多华)
5) Doxazosin mesylate tablets
甲磺酸多沙唑嗪片
1.
Related substances of Doxazosin Mesylate tablets can be detected on C18 column at detection wavelength 254 nm.
采用 ＨＰＬＣ法，以Ｃ１８柱检测波长２５４ｎｍ测定甲磺酸多沙唑嗪片有关物质。
6) S-doxazosin mesylate
S-多沙唑嗪甲磺酸盐
1.
Objective To compare the plasma concentrations of S-doxazosin mesylate and S-doxazosin hydrochloride aderministered via digestive system in rats,rabbits and cats,respectively.
目的观察3种动物经消化道给予S-多沙唑嗪甲磺酸盐和S-多沙唑嗪盐酸盐后血药浓度变化。
补充资料：甲磺酸多沙唑嗪
分子式：C24H29N5O8S
分子量：547.58
CAS号：77883-43-3
性质：外观： 白色或类白色结晶性粉末有关物质： ≤1.0%干燥失重： ≤1.0%炽灼残渣： ≤0.1%重金属： ≤10ppm含量： ≥99.0%
制备方法：暂无
用途：治疗高血压。
分子量：547.58
CAS号：77883-43-3
性质：外观： 白色或类白色结晶性粉末有关物质： ≤1.0%干燥失重： ≤1.0%炽灼残渣： ≤0.1%重金属： ≤10ppm含量： ≥99.0%
制备方法：暂无
用途：治疗高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条